Inventory Management
Procurement
Method Pay
Analytics & Reporting
Whether you're ordering supplies for one office or fifty, your suppliers are no longer quoting comparable prices. One supplier may be quoting a price based on inventory they bought six months ago. Meanwhile, another is pricing off a container that just cleared customs last week at a dramatically different landed cost.
Two suppliers quoting the identical product can now be 30 to 50% apart on price. Here's what's driving it and how to mitigate the effects.
For most of the last two decades, dental supply pricing was relatively stable and predictable. The major distributors largely were buying from the same manufacturers, importing through the same channels. Their pricing practices reflected that parity.
If you were comparing quotes across your two or three suppliers, you might see differences of 10 to 15% on certain products. Meaningful, but manageable and relatively predictable. Today, those gaps have ballooned to 30, 40, even 50% or more on the same items.
That's a fundamentally different landscape.
What we're seeing right now is the most volatile dental supply market in at least 25 years, except during COVID. The pandemic created a demand shock. Everyone needed the same products (PPE and disinfectants) at the same time, and supply couldn't keep up.
And by several measures, what's happening now is comparable. What we're facing today is a cost shock, driven by forces that are harder to see and harder to predict, but just as disruptive to your bottom line. Unlike COVID, where the disruption was concentrated in a handful of categories like PPE and disinfectants, this volatility is touching every petroleum-based product in your supply chain simultaneously.
Five factors (tariffs, petroleum costs, geopolitical conflict, supply chain disruptions, and raw material shortages) are creating pricing disparities across suppliers that would have been unthinkable just a few years ago.
Start with tariffs and understand that there isn't a single tariff. There are multiple layers stacked on top of each other.
The Section 301 tariff on medical-grade nitrile gloves from China hit 100% in January 2026, doubling from the 50% rate set in 2025. Syringes and needles from China are also at 100%.
These are permanent. They have no expiration date and were unaffected by the Supreme Court's February ruling striking down the IEEPA tariffs. On top of that, the administration imposed a separate 10% surcharge on virtually all imports under Section 122 of the Trade Act.
For a dental practice or DSO ordering gloves, those layers stack. It’s a structural repricing of one of the highest-volume consumables in every operatory.
Another major factor is oil.
Nitrile gloves are made from nitrile butadiene rubber, a synthetic copolymer derived directly from petroleum. The two key raw materials, acrylonitrile and butadiene, are petrochemical derivatives, which means every barrel of crude that gets more expensive makes every glove more expensive.
Butadiene prices surged 88% between November 2025 and March 2026. Manufacturers have responded with wholesale price increases of up to 40%.
Every petroleum-based product in your supply chain is affected. Nitrile and vinyl gloves, HVE tips, saliva ejectors, disposable prophy angles, air/water syringe tips, barrier sleeves, suction tubing, plastic-packaged cotton products, composite syringe delivery systems.
Anything with a synthetic polymer in it is riding the same cost curve. The plastics industry describes it as a cascading chain: petroleum to naphtha to monomers to polymers to finished goods. Polypropylene prices in Europe are up over 30% year-to-date. Some plastic segments have seen increases of up to 50%.
And if your first instinct is to switch from nitrile to vinyl gloves to dodge the tariffs, think again. Vinyl gloves are made from polyvinyl chloride, a petroleum-derived polymer. The same oil price dynamics that are driving nitrile costs are hitting vinyl right alongside them. There's no easy material substitution to sidestep this.
On top of the raw material spike, freight is piling on as a separate cost layer. Transpacific shipping rates climbed nearly 30% between late February and early April. War-risk insurance premiums for Strait of Hormuz transit jumped from 0.125% to as high as 0.4% of ship insurance value per crossing.
For a large tanker, that's an additional quarter of a million dollars per trip. Those costs don't show up on a raw materials report. They get baked into the landed cost of every container, and they hit suppliers unevenly depending on when their last shipment arrived.
As Fastenal CEO Dan Florness told investors on the company's Q1 earnings call, nitrile glove pricing is surging specifically because the product is petroleum-based, and the percentage swings are making recent tariff increases look small by comparison. That's a $7 billion distributor confirming what every dental buyer is starting to feel at the register.
And then there's the geopolitical dimension that's supercharging the effects of the other four.
The closure of the Strait of Hormuz, through which roughly 20% of the world's seaborne oil trade flows, has created what the International Energy Agency has called the largest supply disruption in the history of the global oil market.
Brent crude has climbed past $100 per barrel and hasn't looked back. Rerouting shipments around the Cape of Good Hope adds 10 to 14 days of transit time, spiking fuel costs and triggering war-risk insurance surcharges that get folded right into the price of goods.
The biggest struggle facing practices is these effects aren't uniform. They're hitting suppliers at different times, at different rates, depending on when they last placed an order and what they paid to get it here. And what's most important to understand: your suppliers can't control any of this.
They're not inflating prices by their own whims. They're reacting to a set of compounding external forces (tariff layers, petroleum spikes, freight surcharges, insurance premiums, raw material shortages) that land on their books at different times depending on their purchasing cycle and inventory position.
The result is that two suppliers who used to quote you within a percentage point or two on the same box of gloves may now be 30 to 40% apart. Not because one is gouging you, but because one absorbed their costs three months before the other.
As if there weren’t enough variables involved, the response from suppliers could be making this worse. Some distributors are stockpiling aggressively, pre-buying large quantities to lock in current pricing before the next wave of increases.
That behavior depletes available inventory across the channel and creates artificial scarcity for everyone else. Some suppliers are already imposing purchase limits on certain items to prevent premature stockouts. The result is that the gap between a well-positioned supplier and a supply-constrained one isn't just a price gap anymore. It can be an availability gap. And if your primary supplier can't fill an order, you need to know instantly which of your other suppliers can, and at what price.
Here's where it gets interesting for buyers and where most practices, whether you're a single-location office or a multi-site DSO, are potentially overspending when they don’t need to.
In a stable market, it didn't matter much when your supplier last restocked. The big distributors were all paying roughly the same cost for the same products, and their pricing to you reflected that. But when you have this many compounding cost factors shifting simultaneously (tariffs, petroleum, freight, raw materials), the timing of a supplier's last purchase becomes everything.
This is the supplier inventory clock, and it's the single most important variable in your procurement costs right now.
The only way to control this variable is with real-time visibility
Here's the catch: most dental buyers have no mechanism to see this in real time. The problem looks different depending on your size, but the impact is the same.
If you're a private practice working with two or three preferred suppliers, you're likely placing orders with one of them out of habit, convenience, or relationship. Maybe you check pricing once a quarter.
Maybe your office manager has a general sense of who's cheaper on what. But in a market moving this fast, a quarterly price check is a rearview mirror. The landscape can shift materially in a matter of weeks. A practice that spends $40,000 to $60,000 a year on supplies could be overpaying by thousands simply because it didn't realize its secondary supplier offered better pricing on the items it ordered last Tuesday.
If you're a DSO, the scale of the problem multiplies. You may have negotiated pricing across your locations, but those contracts were based on a cost environment that no longer exists.
Your suppliers are honoring what they can for as long as they can, but as their inventory turns over and new costs come in, the pricing you locked in six months ago may no longer reflect what's available from a competitor today. Multiply that gap across 20, 50, or 100 locations, and the dollars add up fast.
This is exactly what Method was built for: showing every dental supply buyer the real price of every product across all their suppliers, in real time, before the order goes out.
In short, this kind of comparison is nearly impossible to do manually for a few reasons. You'd have to know that the same product exists across multiple suppliers, often under different supplier-specific SKUs and product names.
Then you'd need to pull up each supplier's current price, determine which price source is actually the best available (is it the contract price? the public price? A quoted price your rep gave you last month?), and repeat for every item on your order. Nobody has time for that, so most practices don't do it, and they end up ordering from whoever they ordered from last time.
Method eliminates that problem through product normalization and cross-referencing at scale.
Method's catalog covers over 800,000 dental products across virtually every major supplier, and every product is organized into a normalized taxonomy of categories and product types.
Critically, products are clustered so that the same item, sold by different suppliers, retains a consistent identity. That normalization is what makes true cross-supplier comparison possible. Not just at the SKU level, but at the product level, which is how dental teams actually think about what they're buying.
On top of that, the normalization layer sits on Method's cost analysis engine. The cost analysis screen presents a grid with your products listed vertically and your preferred suppliers across the top. For each product, the grid shows each supplier's price, with a visual indicator highlighting the lowest price.
And here's the part that matters in a volatile market: the price shown for each supplier is already the lowest valid price available from that supplier, whether it's a live practice-specific contract price, a public catalog price, or a quoted price loaded from an RFP or rep negotiation. Method runs that three-source comparison automatically before the analysis even begins, so every number on the screen is already the best available from each source.
From there, the practice selects how many preferred suppliers they want to order from: one, two, three, or however many makes sense. With one click, Method calculates the optimal combination of suppliers that yields the lowest total cost basket subject to that constraint. The entire process takes 30 seconds or less. No spreadsheets. No browser tabs. No guesswork.
In a stable market, this saves time and money. In the market we're in right now, with compounding cost factors creating massive pricing disparities across suppliers that change week to week, it's the difference between buying blind and buying smart. And it doesn't slow down the ordering process. It is the ordering process.
This isn't about squeezing suppliers or being adversarial. It's about making an informed decision at a time when the spread between your best and worst option on any given product could be the widest it's been in years. When preferred suppliers know that every line item is being compared systematically, suppliers that aren't winning on price have a natural incentive to sharpen their pricing to compete. Over time, that creates downward pressure across your entire supplier base. Not through confrontation, but through transparency.
There's a temptation to treat this as a temporary disruption. Wait it out, absorb the cost, adjust later. But the structural forces driving volatility aren't resolving quickly, and they aren't resolving at the same time.
The tariffs have no expiration date. The Strait of Hormuz at the time of this writing is functionally closed to normal traffic.
DSOs that absorbed 8% to 20% of supply cost increases during the first wave in 2025, driven primarily by tariffs, are now facing a second wave fueled by the petroleum and shipping crises, with no margin left to absorb them. Private practices are feeling it just as acutely. A solo practitioner or small group practice doesn't have a procurement team or a GPO contract to fall back on.
They're often absorbing these increases directly and being forced into uncomfortable choices between raising patient fees, reducing staff, or accepting thinner margins. And with dental practice overhead climbing faster than inflation, up 3% annually according to the ADA, every point of unnecessary spend on supplies is compounding the pressure.
The practices and organizations that will navigate this best, from single-office practitioners to enterprise DSOs, are those treating procurement not as an administrative task but as a strategic function. One that requires real-time data, multi-supplier visibility, and the ability to act on price disparities the moment they appear, without adding friction to the buying process.
Because in a market like this, the cost of not looking is the most expensive decision you'll make.
